Patents by Inventor Stéphane LeClair

Stéphane LeClair has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment for multiple myeloma (MM)
    Patent number: 11591406
    Abstract: The present disclosure relates to the treatment of multiple myeloma. Monoclonal antibody MOR202 is efficacious when administered to patient at certain dosage regimens.
    Type: Grant
    Filed: November 25, 2019
    Date of Patent: February 28, 2023
    Assignee: MORPHOSYS AG
    Inventors: Stéphane LeClair, Jan Endell, Stefan Härtle
  • TREATMENT FOR MULTIPLE MYELOMA (MM)
    Publication number: 20200079871
    Abstract: The present disclosure relates to the treatment of multiple myeloma. Monoclonal antibody MOR202 is efficacious when administered to patient at certain dosage regimens.
    Type: Application
    Filed: November 25, 2019
    Publication date: March 12, 2020
    Inventors: Stéphane LeClair, Jan Endell, Stefan Härtle
  • Treatment for multiple myeloma (MM)
    Patent number: 10533057
    Abstract: The present disclosure relates to the treatment of multiple myeloma. Monoclonal antibody MOR202 is efficacious when administered to patient at certain dosage regimens.
    Type: Grant
    Filed: May 13, 2016
    Date of Patent: January 14, 2020
    Assignee: MORPHOSYS AG
    Inventors: Stéphane LeClair, Jan Endell, Stefan Härtle
  • TREATMENT FOR MULTIPLE MYELOMA (MM)
    Publication number: 20190048091
    Abstract: The present disclosure relates to the treatment of multiple myeloma. Monoclonal antibody MOR202 is efficacious when administered to patient at certain dosage regimens.
    Type: Application
    Filed: May 13, 2016
    Publication date: February 14, 2019
    Inventors: Stéphane LeClair, Jan Endell, Stefan Härtle